BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34782853)

  • 1. Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway.
    Wang H; Zuo J
    Anal Cell Pathol (Amst); 2021; 2021():6435393. PubMed ID: 34782853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
    Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L
    Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.
    Li B; Yuan Z; Jiang J; Rao Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
    Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
    BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo.
    Singh T; Sharma SD; Katiyar SK
    PLoS One; 2011; 6(11):e27444. PubMed ID: 22087318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.
    Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC
    Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
    Yingkun N; Lvsong Z; Huimin Y
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.
    Jing H; Sun W; Fan J; Zhang Y; Yang J; Jia J; Li J; Guo J; Luo S; Zheng Y
    Mol Med Rep; 2016 Apr; 13(4):3009-16. PubMed ID: 26935874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms behind the inhibition of lung adenocarcinoma cell by shikonin.
    Lan W; Wan S; Gu W; Wang H; Zhou S
    Cell Biochem Biophys; 2014 Nov; 70(2):1459-67. PubMed ID: 24972691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.
    Huang WR; Zhang Y; Tang X
    Molecules; 2014 Jun; 19(6):7785-97. PubMed ID: 24962386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
    Yang Q; Ji M; Guan H; Shi B; Hou P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
    Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway.
    Zhai T; Hei Z; Ma Q; Liang H; Xu Y; Zhang Y; Jin L; Han C; Wang J
    Oncol Rep; 2017 Dec; 38(6):3473-3480. PubMed ID: 29039581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer.
    Zang F; Rao Y; Zhu X; Wu Z; Jiang H
    Mol Med; 2020 Apr; 26(1):28. PubMed ID: 32268876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.
    Ai X; Mao F; Shen S; Shentu Y; Wang J; Lu S
    BMC Cancer; 2018 Apr; 18(1):407. PubMed ID: 29642873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24).
    Yeh CC; Kuo HM; Li TM; Lin JP; Yu FS; Lu HF; Chung JG; Yang JS
    In Vivo; 2007; 21(6):1011-9. PubMed ID: 18210748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
    Tang JC; Ren YG; Zhao J; Long F; Chen JY; Jiang Z
    Life Sci; 2018 Jul; 204():71-77. PubMed ID: 29738778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.